000			02065 a2200613 4500
005			20250517105125.0
264		0	_c20170214
008			201702s 0 0 eng d
022			_a2352-3964
024	7		_a10.1016/j.ebiom.2016.04.037 _2doi
040			_aNLM _beng _cNLM
100	1		_aSinnberg, Tobias
245	0	0	_aA Nexus Consisting of Beta-Catenin and Stat3 Attenuates BRAF Inhibitor Efficacy and Mediates Acquired Resistance to Vemurafenib. _h[electronic resource]
260			_bEBioMedicine _cJun 2016
300			_a132-149 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aGene Knockdown Techniques
650	0	4	_aHumans
650	0	4	_aIndoles _xpharmacology
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMice
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins B-raf _xantagonists & inhibitors
650	0	4	_aResin Cements
650	0	4	_aSTAT3 Transcription Factor _xmetabolism
650	0	4	_aSulfonamides _xpharmacology
650	0	4	_aVemurafenib
650	0	4	_aWnt Signaling Pathway _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
650	0	4	_abeta Catenin _xgenetics
700	1		_aMakino, Elena
700	1		_aKrueger, Marcel A
700	1		_aVelic, Ana
700	1		_aMacek, Boris
700	1		_aRothbauer, Ulrich
700	1		_aGroll, Nicola
700	1		_aPötz, Oliver
700	1		_aCzemmel, Stefan
700	1		_aNiessner, Heike
700	1		_aMeier, Friedegund
700	1		_aIkenberg, Kristian
700	1		_aGarbe, Claus
700	1		_aSchittek, Birgit
773	0		_tEBioMedicine _gvol. 8 _gp. 132-149
856	4	0	_uhttps://doi.org/10.1016/j.ebiom.2016.04.037 _zAvailable from publisher's website
999			_c26237610 _d26237610